• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从14至22岁意大利学生中分离出的脑膜炎奈瑟菌携带菌株的分子和血清学多样性。

Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

作者信息

Gasparini Roberto, Comanducci Maurizio, Amicizia Daniela, Ansaldi Filippo, Canepa Paola, Orsi Andrea, Icardi Giancarlo, Rizzitelli Emanuela, De Angelis Gabriella, Bambini Stefania, Moschioni Monica, Comandi Sara, Simmini Isabella, Boccadifuoco Giueseppe, Brunelli Brunella, Giuliani Marzia Monica, Pizza Mariagrazia, Panatto Donatella

机构信息

Department of Health Sciences, University of Genoa, Genoa, Italy

Novartis Vaccines and Diagnostics, Siena, Italy.

出版信息

J Clin Microbiol. 2014 Jun;52(6):1901-10. doi: 10.1128/JCM.03584-13. Epub 2014 Mar 19.

DOI:10.1128/JCM.03584-13
PMID:24648565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4042792/
Abstract

Neisseria meningitidis is an obligate human commensal that commonly colonizes the oropharyngeal mucosa. Carriage is age dependent and very common in young adults. The relationships between carriage and invasive disease are not completely understood. In this work, we performed a longitudinal carrier study in adolescents and young adults (173 subjects). Overall, 32 subjects (18.5%) had results that were positive for meningococcal carriage in at least one visit (average monthly carriage rate, 12.1%). Only five subjects tested positive at all four visits. All meningococcal isolates were characterized by molecular and serological techniques. Multilocus sequence typing, PorA typing, and sequencing of the 4CMenB vaccine antigens were used to assess strain diversity. The majority of positive subjects were colonized by capsule null (34.4%) and capsular group B strains (28.1%), accounting for 23.5% and 29.4% of the total number of isolates, respectively. The fHbp and nhba genes were present in all isolates, while the nadA gene was present in 5% of the isolates. The genetic variability of the 4CMenB vaccine antigens in this collection was relatively high compared with that of other disease-causing strain panels. Indications about the persistence of the carriage state were limited to the time span of the study. All strains isolated from the same subject were identical or cumulated minor changes over time. The expression levels and antigenicities of the 4CMenB vaccine antigens in each strain were analyzed by the meningococcal antigen typing system (MATS), which revealed that expression can change over time in the same individual. Future analysis of antigen variability and expression in carrier strains after the introduction of the MenB vaccine will allow for a definition of its impact on nasopharyngeal/oropharyngeal carriage.

摘要

脑膜炎奈瑟菌是一种专性寄生于人类的微生物,通常定殖于口咽黏膜。携带情况与年龄相关,在年轻人中非常普遍。携带与侵袭性疾病之间的关系尚未完全明确。在本研究中,我们对青少年和年轻人(173名受试者)进行了一项纵向携带者研究。总体而言,32名受试者(18.5%)在至少一次访视中脑膜炎球菌携带检测结果呈阳性(平均每月携带率为12.1%)。只有5名受试者在所有4次访视中检测均呈阳性。所有脑膜炎球菌分离株均采用分子和血清学技术进行鉴定。使用多位点序列分型、PorA分型以及4CMenB疫苗抗原测序来评估菌株多样性。大多数阳性受试者被无荚膜菌株(34.4%)和B群荚膜菌株(28.1%)定殖,分别占分离株总数的23.5%和29.4%。所有分离株中均存在fHbp和nhba基因,而nadA基因仅在5%的分离株中存在。与其他致病菌株组相比,该样本中4CMenB疫苗抗原的遗传变异性相对较高。关于携带状态持续时间的信息仅限于研究时间段。从同一受试者分离出的所有菌株在一段时间内要么完全相同,要么累积了微小变化。通过脑膜炎球菌抗原分型系统(MATS)分析了各菌株中4CMenB疫苗抗原的表达水平和抗原性,结果显示同一受试者体内的表达水平可能随时间变化。在引入MenB疫苗后,对携带者菌株中抗原变异性和表达情况的进一步分析将有助于明确其对鼻咽/口咽携带的影响。

相似文献

1
Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.从14至22岁意大利学生中分离出的脑膜炎奈瑟菌携带菌株的分子和血清学多样性。
J Clin Microbiol. 2014 Jun;52(6):1901-10. doi: 10.1128/JCM.03584-13. Epub 2014 Mar 19.
2
Carriage meningococcal isolates with capsule null locus dominate among high school students in a non-endemic period, Italy, 2012-2013.2012-2013 年,意大利非流行期间,带荚膜空突变体的脑膜炎奈瑟菌分离株在高中生中占主导地位。
Int J Med Microbiol. 2019 May-Jun;309(3-4):182-188. doi: 10.1016/j.ijmm.2019.03.004. Epub 2019 Mar 6.
3
Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.2015-2016 年美国三所大学学生携带的脑膜炎 B 型疫苗抗原的遗传多样性。
mBio. 2021 May 18;12(3):e00855-21. doi: 10.1128/mBio.00855-21.
4
Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets.2009 - 2013年加拿大魁北克B群脑膜炎奈瑟菌侵袭性菌株在B群疾病增加期间的特征分析:表型分析和基因分型,特别强调非碳水化合物蛋白疫苗靶点
BMC Microbiol. 2015 Jul 25;15:143. doi: 10.1186/s12866-015-0469-6.
5
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Isolated from 2009 to 2013 in the Republic of Ireland.爱尔兰共和国 2009 至 2013 年分离的侵袭性 B 群血清型 4CMenB 疫苗的潜在覆盖范围。
mSphere. 2018 Aug 22;3(4):e00196-18. doi: 10.1128/mSphere.00196-18.
6
Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.在芬兰,对脑膜炎奈瑟菌的带菌者和侵袭性疾病分离株进行基因和表型特征分析。
J Clin Microbiol. 2012 Feb;50(2):264-73. doi: 10.1128/JCM.05385-11. Epub 2011 Nov 30.
7
Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis.4CMenB 疫苗对接种者口腔脑膜炎奈瑟菌带菌状况的潜在影响。
J Infect. 2017 Dec;75(6):511-520. doi: 10.1016/j.jinf.2017.09.021. Epub 2017 Oct 5.
8
Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014.2009年6月至2014年1月从克罗地亚收集的脑膜炎奈瑟菌分离株的分子特征
J Med Microbiol. 2016 Sep;65(9):1013-1019. doi: 10.1099/jmm.0.000320. Epub 2016 Jul 22.
9
Increase of Neisseria meningitidis W:cc11 invasive disease in Chile has no correlation with carriage in adolescents.智利侵袭性脑膜炎奈瑟菌 W:cc11 疾病的增加与青少年带菌无关。
PLoS One. 2018 Mar 8;13(3):e0193572. doi: 10.1371/journal.pone.0193572. eCollection 2018.
10
Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.在引进A群脑膜炎球菌结合疫苗之前布基纳法索的脑膜炎球菌带菌情况基线。
Clin Vaccine Immunol. 2011 Mar;18(3):435-43. doi: 10.1128/CVI.00479-10. Epub 2011 Jan 12.

引用本文的文献

1
Factor H binding protein (FHbp): An evaluation of genotypic diversity across serogroups.因子 H 结合蛋白(FHbp):对各血清群的基因多样性评估。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2409502. doi: 10.1080/21645515.2024.2409502. Epub 2024 Oct 10.
2
Microevolution and Its Impact on Hypervirulence, Antimicrobial Resistance, and Vaccine Escape in .微进化及其对……中高毒力、抗菌药物耐药性和疫苗逃逸的影响
Microorganisms. 2023 Dec 18;11(12):3005. doi: 10.3390/microorganisms11123005.
3
Prevalence and Characteristics of Carriage of Among Young Israeli Adults.以色列年轻成年人中[具体内容缺失]携带情况的患病率及特征
Open Forum Infect Dis. 2022 Sep 19;9(10):ofac482. doi: 10.1093/ofid/ofac482. eCollection 2022 Oct.
4
Meningococcal Disease in Pediatric Age: A Focus on Epidemiology and Prevention.小儿脑膜炎球菌病:关注流行病学和预防。
Int J Environ Res Public Health. 2022 Mar 29;19(7):4035. doi: 10.3390/ijerph19074035.
5
Genomic Insights on Variation Underlying Capsule Expression in Meningococcal Carriage Isolates From University Students, United States, 2015-2016.2015 - 2016年美国大学生脑膜炎球菌携带分离株中荚膜表达潜在变异的基因组见解
Front Microbiol. 2022 Feb 17;13:815044. doi: 10.3389/fmicb.2022.815044. eCollection 2022.
6
[ (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy].[意大利引入四价结合疫苗进行抗脑膜炎球菌疫苗接种的(卫生技术评估)]
J Prev Med Hyg. 2021 May 13;62(1 Suppl 1):E1-E128. doi: 10.15167/2421-4248/jpmh2021.62.1s1. eCollection 2021 Mar.
7
Longitudinal study of meningococcal carriage rates in university entrants living in a dormitory in South Korea.韩国宿舍居住的大学生中新隐球菌携带率的纵向研究。
PLoS One. 2021 Jan 28;16(1):e0244716. doi: 10.1371/journal.pone.0244716. eCollection 2021.
8
Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence.为何意大利应在青少年时期实施B型脑膜炎球菌疫苗接种:现有证据概述
Microorganisms. 2020 Oct 29;8(11):1681. doi: 10.3390/microorganisms8111681.
9
Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy.意大利侵袭性脑膜炎球菌病:从全国数据分析到基于证据的疫苗接种策略。
J Prev Med Hyg. 2020 Jul 4;61(2):E152-E161. doi: 10.15167/2421-4248/jpmh2020.61.2.1589. eCollection 2020 Jun.
10
[Health Technology Assessment of meningococcal B vaccine (Trumenba) in adolescent in Italy].[意大利青少年群体中B型脑膜炎球菌疫苗(Trumenba)的卫生技术评估]
J Prev Med Hyg. 2019 Dec 19;60(3 Suppl 2):E1-E94. doi: 10.15167/2421-4248/jpmh2019.60.3s2. eCollection 2019 Dec.

本文引用的文献

1
A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?一种多组份 B 群脑膜炎球菌疫苗在欧洲获准使用:我们对此了解多少,还有哪些方面有待了解?
Expert Rev Vaccines. 2013 Aug;12(8):837-58. doi: 10.1586/14760584.2013.814862.
2
Conservation of meningococcal antigens in the genus Neisseria.脑膜炎奈瑟菌属中脑膜炎球菌抗原的保守性。
mBio. 2013 Jun 11;4(3):e00163-13. doi: 10.1128/mBio.00163-13.
3
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.预测脑膜炎球菌多组份疫苗(4CMenB)在欧洲的菌株覆盖率:定性和定量评估。
Lancet Infect Dis. 2013 May;13(5):416-25. doi: 10.1016/S1473-3099(13)70006-9. Epub 2013 Feb 13.
4
Infant meningococcal vaccination: Advisory Committee on Immunization Practices (ACIP) recommendations and rationale.婴儿脑膜炎球菌疫苗接种:免疫实践咨询委员会(ACIP)的建议和基本原理。
MMWR Morb Mortal Wkly Rep. 2013 Jan 25;62(3):52-4.
5
Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease.二价rLP2806疫苗对脑膜炎奈瑟菌携带及B群侵袭性疾病的潜在影响。
Hum Vaccin Immunother. 2013 Mar;9(3):471-9. doi: 10.4161/hv.23222. Epub 2012 Dec 18.
6
Neisseria meningitidis, pathogenetic mechanisms to overcome the human immune defences.脑膜炎奈瑟菌,克服人体免疫防御的致病机制。
J Prev Med Hyg. 2012 Jun;53(2):50-5.
7
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.为MATS设计的夹心酶联免疫吸附测定的实验室间标准化,MATS是一种用于评估研究性疫苗菌株覆盖率的快速、可重复的方法。
Clin Vaccine Immunol. 2012 Oct;19(10):1609-17. doi: 10.1128/CVI.00202-12. Epub 2012 Aug 8.
8
Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease.脑膜炎球菌疫苗的研发——从针对 MenACWY 的糖缀合物到针对 MenB 的蛋白——针对脑膜炎球菌病的广泛保护潜力。
Vaccine. 2012 May 30;30 Suppl 2:B18-25. doi: 10.1016/j.vaccine.2012.01.062.
9
The changing and dynamic epidemiology of meningococcal disease.脑膜炎奈瑟菌病的变化和动态流行病学。
Vaccine. 2012 May 30;30 Suppl 2:B26-36. doi: 10.1016/j.vaccine.2011.12.032. Epub 2011 Dec 15.
10
Capsule null locus meningococci: typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine.胶囊缺失奈瑟菌:在一种研究性多组分脑膜炎奈瑟菌 B 群疫苗中使用的抗原分型。
Vaccine. 2012 Jan 5;30(2):155-60. doi: 10.1016/j.vaccine.2011.11.050. Epub 2011 Nov 19.